CG Oncology (CGON) reported a Q1 net loss Friday of $0.71 per share, widening from a loss of $0.45 a year earlier.
Analysts polled by FactSet expected a loss of $0.56.
Total revenue for the quarter ended March 31 was $1.1 million, up from $52,000 a year earlier.
Analysts surveyed by FactSet expected $500,000.